炎症性腸疾患の検知のための潜在的な標的の特定:精密な予防に向けて
Sun-Ho Lee1,2, Emily Lopes3,4, Jean-Frederic Colombel5
1Division of Gastroenterology & Hepatology, Termerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Inflammatory bowel diseases
|August 20, 2025
まとめ
免疫系,微生物群,腸内障壁の初期変化が 炎症性腸疾患 (IBD) に先行する. これらの前臨床的兆候を特定することで,病気の進行を検知する精密な予防戦略が可能になります.
科学分野:
- 胃腸内科と免疫学
- 微生物群の研究
- 病気 の 予防
背景:
- クローン病 (CD) と潰瘍性大腸炎 (UC) を含む炎症性腸疾患 (IBD) は,検知可能な免疫,微生物群および障壁の変化を有する臨床前段階である.
- これらの早期の変化は 臨床診断の数年前から起きており 介入の機会を提示しています
研究 の 目的:
- IBDを誘発する環境的,微生物的,分子的要因に関する証拠をレビューする.
- IBDの修正可能なリスク経路と予防戦略を探求する.
- 正確な予防のための新しいバイオマーカーを強調する.
主な方法:
- IBD前臨床段階に関する現在の科学文献のレビュー.
- 環境,微生物,分子因子の分析
- 新興バイオマーカーと予防戦略の検討
主要な成果:
- 臨床前段階でIBDの発症に寄与する主要な要因を特定した.
- IBDの予防のための生活様式,環境,そして標的の介入について議論しました.
- 抗フラゲリン抗体や リスク層別化のためのグリコミックプロファイルなどの新しいバイオマーカーを強調した.
結論:
- 臨床前IBDマーカーの早期発見は,標的を絞った予防を可能にします.
- 個々のリスク生物学に合わせた 精密な予防戦略は IBDのケアを 治療から予防に移すことができます
- UCの臨床前の洞察については,さらなる研究が必要である.
関連する概念動画
01:29Inflammatory Bowel Disease IV: Pharmacological Management
189
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
189
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
419
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
419
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
231
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
231
01:21Inflammatory Bowel Disease V: Surgical Management
212
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
212
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
321
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
321
01:30Inflammatory Bowel Disease II: Crohn's Disease
382
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
382